{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T00:08:00Z","timestamp":1759018080624,"version":"3.44.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,4,1]],"date-time":"2006-04-01T00:00:00Z","timestamp":1143849600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2006,4]]},"DOI":"10.1016\/j.jinf.2005.07.003","type":"journal-article","created":{"date-parts":[[2005,9,20]],"date-time":"2005-09-20T09:03:42Z","timestamp":1127207022000},"page":"243-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Protective effect of doxycycline use on coronary artery disease?"],"prefix":"10.1016","volume":"52","author":[{"given":"Marina","family":"Kardara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Athanasia","family":"Papazafiropoulou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paraskevi","family":"Katsakiori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chrysanthos","family":"Petropoulos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleni","family":"Jelastopulu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jinf.2005.07.003_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/00019501-199809060-00004","article-title":"Chlamydia pneumoniae, antimicrobial therapy and coronary heart disease: A critical overview","volume":"9","author":"Gupta","year":"1998","journal-title":"Coron Artery Dis"},{"key":"10.1016\/j.jinf.2005.07.003_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0002-8703(99)70269-3","article-title":"Role of infections in atherosclerosis","volume":"138","author":"Valtonen","year":"1999","journal-title":"Am Heart J"},{"key":"10.1016\/j.jinf.2005.07.003_bib3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1056\/NEJM199901143400207","article-title":"Atherosclerosis\u2014an inflammatory disease","volume":"340","author":"Ross","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jinf.2005.07.003_bib4","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1046\/j.1365-2168.1998.00861.x","article-title":"Chlamydia pneumoniae and vascular disease","volume":"85","author":"Gibbs","year":"1998","journal-title":"Br J Surg"},{"key":"10.1016\/j.jinf.2005.07.003_bib5","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1016\/S0140-6736(88)90741-6","article-title":"Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction","volume":"2","author":"Saikku","year":"1988","journal-title":"Lancet"},{"key":"10.1016\/j.jinf.2005.07.003_bib6","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-116-4-273","article-title":"Chronic Chlamydia pneumoniae infection as a risk factor for coronary heart disease in the Helsinki heart study","volume":"116","author":"Saikku","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jinf.2005.07.003_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0163-4453(95)80006-9","article-title":"Chlamydia pneumoniae: Risk factors for seropositivity and associations with coronary artery disease","volume":"30","author":"Mendall","year":"1995","journal-title":"J Infect"},{"key":"10.1016\/j.jinf.2005.07.003_bib8","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1001\/jama.1992.03490010070032","article-title":"Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease","volume":"268","author":"Thon","year":"1992","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jinf.2005.07.003_bib9","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1161\/01.CIR.96.2.404","article-title":"Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction","volume":"96","author":"Gupta","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/j.jinf.2005.07.003_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1053\/euhj.1998.1283","article-title":"Treatment with the antibiotic roxithromycin in patients with acute non Q-wave coronary symptoms. The final report of the ROXIS study","volume":"20","author":"Gurfinkel","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jinf.2005.07.003_bib11","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1161\/01.CIR.99.12.1540","volume":"99","author":"Anderson","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.jinf.2005.07.003_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.281.5.427","article-title":"Antibiotics and risk of subsequent first-time acute myocardial infarction","volume":"281","author":"Meier","year":"1999","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.jinf.2005.07.003_bib13","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3201\/eid0502.990216","article-title":"Lack of association between first myocardial infarction and past use of erythromycin, tetracycline, or doxycycline","volume":"5","author":"Jackson","year":"1999","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.jinf.2005.07.003_bib14","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/clinids\/14.1.178","article-title":"Persistent infection with Chlamydia pneumoniae following acute respiratory illness","volume":"14","author":"Hammerschlag","year":"1992","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jinf.2005.07.003_bib15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1128\/AAC.36.7.1573","article-title":"In vitro activities of azithromycin, clarithromycin, l-ofloxacin, and other antibiotics against Chlamydia pneumoniae","volume":"36","author":"Hammerschlag","year":"1992","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2005.07.003_bib16","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1093\/jac\/34.6.1072","article-title":"Susceptibility of Chlamydia pneumoniae to oral agents commonly used in the treatment of respiratory infection","volume":"34","author":"Beale","year":"1994","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.jinf.2005.07.003_bib17","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1128\/AAC.38.9.1873","article-title":"Antimicrobial susceptibility and therapy of infections caused by Chlamydia pneumoniae","volume":"38","author":"Hammerschlag","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2005.07.003_bib18","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1128\/AAC.40.11.2669","article-title":"In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae","volume":"40","author":"Kuo","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jinf.2005.07.003_bib19","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1128\/AAC.42.10.2762","article-title":"In vitro susceptibilities of Chlamydia pneumoniae strains recovered from atherosclerotic coronary arteries","volume":"42","author":"Gieffers","year":"1998","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344530500201X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344530500201X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T15:29:39Z","timestamp":1758986979000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016344530500201X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,4]]},"references-count":19,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2006,4]]}},"alternative-id":["S016344530500201X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2005.07.003","relation":{},"ISSN":["0163-4453"],"issn-type":[{"type":"print","value":"0163-4453"}],"subject":[],"published":{"date-parts":[[2006,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protective effect of doxycycline use on coronary artery disease?","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2005.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 The British Infection Society. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}